Floatz logo

30 assets in Smoldering Plasma Cell Myeloma

Therapeutic assets addressing Smoldering Plasma Cell Myeloma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Dexasone
Smoldering Plasma Cell Myeloma
Regeneron PharmaceuticalsP3BB (68)
Nivestim
Smoldering Plasma Cell Myeloma
Regeneron PharmaceuticalsP3BB (68)
Lenalidomide
Smoldering Plasma Cell Myeloma
Irene Ghobrial, MDP3BB (66)
Linvoseltamab
Smoldering Plasma Cell Myeloma
Regeneron PharmaceuticalsP3BB (66)
Daratumumab
Smoldering Plasma Cell Myeloma
Regeneron PharmaceuticalsP3BB (65)
Cyclophosphamide
Smoldering Plasma Cell Myeloma
Dana-Farber Cancer InstituteP2B (63)
Melphalan
Smoldering Plasma Cell Myeloma
PETHEMA FoundationP3B (62)
Bortezomib
Smoldering Plasma Cell Myeloma
Omar Nadeem, MDP2B (60)
Leflunomide
Smoldering Plasma Cell Myeloma
City of Hope Medical CenterP2B (60)
Nivolumab
Smoldering Plasma Cell Myeloma
Massachusetts General HospitalP2B (60)
Carfilzomib
Smoldering Plasma Cell Myeloma
Landspitali University HospitalP2CCC (53)
Cholestyramine
Smoldering Plasma Cell Myeloma
City of Hope Medical CenterP2CCC (53)
Ciltacabtagene Autoleucel
Smoldering Plasma Cell Myeloma
Dana-Farber Cancer InstituteP2CCC (53)
Cilta-Cel
Smoldering Plasma Cell Myeloma
PETHEMA FoundationP2CCC (53)
Elranatamab
Smoldering Plasma Cell Myeloma
Stichting European Myeloma NetworkP2CCC (53)
Fludarabine
Smoldering Plasma Cell Myeloma
Dana-Farber Cancer InstituteP2CCC (53)
Iberdomide
Smoldering Plasma Cell Myeloma
Emory UniversityP2CCC (53)
Isatuximab
Smoldering Plasma Cell Myeloma
University College, LondonP2CCC (53)
Metformin
Smoldering Plasma Cell Myeloma
Dana-Farber Cancer InstituteP2CCC (53)
Pomalidomide
Smoldering Plasma Cell Myeloma
Mayo ClinicP2CCC (53)
Selinexor
Smoldering Plasma Cell Myeloma
University of RochesterP2CCC (53)
Teclistamab
Smoldering Plasma Cell Myeloma
Irene Ghobrial, MDP2CCC (53)
tg01
Smoldering Plasma Cell Myeloma
Oslo University HospitalP1/2CC (45)
Pvx-410
Smoldering Plasma Cell Myeloma
Massachusetts General HospitalP1CC (44)
Atezolizumab
Smoldering Plasma Cell Myeloma
Massachusetts General HospitalP1CC (43)
Citarinostat
Smoldering Plasma Cell Myeloma
Massachusetts General HospitalP1CC (41)
Dickkopf-Related Protein 1
Smoldering Plasma Cell Myeloma
Case Comprehensive Cancer CenterEarly P1C (39)
Pembrolizumab
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer CenterEarly P1C (39)
Apsolol
Smoldering Plasma Cell Myeloma
Roswell Park Cancer InstituteN/AD (30)
CM336
Smoldering Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, ChinaN/AD (30)